ArticleViruses2026
Phylogenetic Analysis of Foot-and-Mouth Disease Virus from Cattle in Nigeria, 2017-2020.
Article in Viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aim of this study was to detect and characterize foot-and-mouth disease virus (FMDV) serotypes circulating in cattle from Nigeria and to determine the genetic relationship with FMDV from previous studies in Nigeria. A cross-sectional study was undertaken between 2017 and 2020, during which a total of 234 epithelial tissue samples were collected from reported outbreaks in nine states across Nigeria over a four-year period. Serotypes O/EA-3 and SAT2/VII were identified in samples from 2017 and 2018, serotypes A/Africa/G-IV and SAT2/VII in 2019, and all three serotypes including O/EA-3 and O/WA were identified in samples from 2020. This study identified the presence of three FMDV serotypes (O/EA-3 and O/WA, A/Africa/G-IV and SAT2/VII) circulating in Nigeria. The three serotypes detected in this study can be recommended for production of the appropriate vaccines to control FMDV in Nigeria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.